Hospitalization and death is more likely among individuals with diabetes when they contract influenza than when healthy individuals do, and so influenza vaccination uptake is an important area of scrutiny.
Diabetes
Latest News
Advertisement
CME Content
Advertisement
This year's top news regarding pharmacy benefit managers.
This year's top 10 top articles about diabetes.
Jardiance reducea the risk of cardiovascular death in adults with type 2 diabetes mellitus and cardiovascular disease.
Clonidine topical gel was not more effective than placebo in reducing pain from diabetic neuropathy.
After 4 weeks of moderate exercise, rat models with diabetes had improved memory function.
Clonidine topical gel fails to achieve desired outcome in reducing pain from diabetic neuropathy.
The placenta diverts blood flow away from the brain in fetuses of mothers with diabetes.
Officials with the FDA have expanded the use of Dexcom’s G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose testing for diabetes treatment decisions in people 2 years of age and older with diabetes,
Tresiba is now indicated to treat patients with diabetes as young as 1-year-old.
Some diabetes drugs are thought to cause weight loss through the hypothalamus, but other parts of the brain may be involved.
Patients with diabetes buying Eli Lilly insulin can potentially save 40% off retail price.
Novo Nordisk submitted the supplemental New Drug Application (sNDA) based on the results of the BEGIN Young 1 trial, a multi-national, 26-week, phase 3b, randomized, controlled, clinical trial.
Researchers discovered a statistically significant link between diabetes and all-cause mortality.
Top articles of the week from The American Journal of Pharmacy Benefits.
FDA-approved drug could reduce the risk of death in adults with diabetes and cardiovascular disease.
Top news of the day from across the health care landscape.
Jardiance could reduce the risk of death in adults with diabetes and cardiovascular disease.
Some conditions associated with type 2 diabetes may significantly impair renal function.
Top news of the day from across the health care landscape.
Inhibiting the SNAP23 protein could lead to increased insulin secretion.
Top news of the day from across the health care landscape.
Pharmacists can assist in patients’ blood glucose control, and provides the same benefit to that of other providers.
The FDA has approved Synjardy XR (empagliflozin and metformin hydrochloride, extended-release) tablets for the treatment of type 2 diabetes in adults. In combination with diet and exercise, Synjardy XR can improve blood sugar in patients.
The combination drug Synjardy XR approved for use in patients with type 2 diabetes.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Notifies Flu Vaccine Makers to Add Warning for Increased Febrile Seizure Risk in Young Children Day Following Vaccination
2
Oral Semaglutide Approved to Reduce the Risk of Cardiovascular Events
3
In 2026, Pharmacists Will Be Driving Change Across the Care Continuum
4
AI-Powered Digital Twins Offer a New Window Into Tumor Metabolism in Brain Cancer
5